Effects of serum magnesium and potassium on the development of strokes and acute myocardial infarction: is it possible to prevent? | Український Медичний Часопис

Hypomagnesemia and hypokalemia are recognized as reliable predictors of stroke and acute myocardial infarction, which is accompanied by an increase in all-cause mortality. Increasing magnesium and potassium intake and achieving target levels of potassium (>4.0 mmol/l) and magnesium (>0.84 mmol/l) can minimize the risk of stroke, acute myocardial infarction, deaths, and atrial fibrillation. Early detection and correction of potassium and magnesium imbalances can contribute to the rapid recovery of patients with acute myocardial infarction and stroke, improve treatment outcomes and restore the functional status of patients. The effectiveness of oral potassium intake is considered equivalent to intravenous administration of solutions of this electrolyte. Panangin Forte is a combined preparation of magnesium asparaginate and potassium asparaginate used to correct hypomagnesemia and hypokalemia. It is advisable to take potassium-magnesium-containing preparations simultaneously with periodic careful monitoring of the levels of these electrolytes. Monitoring magnesium and potassium levels can help physicians identify patients at high risk of recurrent stroke and acute myocardial infarction and determine the population for prescribing magnesium and potassium-containing drugs.

References

1. Arnett D., Blumenthal R., Albert M. et al. (2019) 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation, 140(11): e563–e595. doi: 10.1161/CIR.0000000000000677/.
2. Bilchenko A., Gritsenko O., Kolisnyk V. et al. (2024) Acute myocardial infarction complicated by cardiogenic shock in Ukraine: multicentre registry analysis 2021–2022. Front. Cardiovasc. Med., 11: 1377969. doi: 10.3389/fcvm.2024.1377969.
3. Castro D., Sharma S. Hypokalemia (2024) In: StatPearls. Treasure Island (FL): StatPearls Publ. http://www.ncbi.nlm.nih.gov/books/NBK482465/.
4. Copp K., Steffen L., Yi S. et al. (2024) Magnesium-Rich Diet Score is Inversely Associated with Incident Cardiovascular Disease: The Atherosclerosis in Communities (ARIC) Study. Eur. J. Prev. Cardiol., zwae251. doi: 10.1093/eurjpc/zwae251.
5. Costello R., Rosanoff A., Nielsen F. et al. (2023) Perspective: Call for Re-evaluation of the Tolerable Upper Intake Level for Magnesium Supplementation in Adults. Adv. Nutr., 14(5): 973–982. doi: 10.1016/j.advnut.2023.06.008.
6. D’Elia L., Cappuccio F.P., Masulli M. et al. (2023) Effect of Potassium Supplementation on Endothelial Function: A Systematic Review and Meta-Analysis of Intervention Studies. Nutrients., 15(4): 853. doi: 10.3390/nu15040853.
7. Fan Y., Wu M., Li X. et al. (2024) Potassium levels and the risk of all-cause and cardiovascular mortality among patients with cardiovascular diseases: a meta-analysis of cohort studies. Nutr. J., 23(1): 8. doi: 10.1186/s12937-023-00888-z.
8. Feng C., Peng C., Li C. (2024) Association between Magnesium Depletion Score and stroke in US adults with chronic kidney disease: a population-based study. J. Stroke Cerebrovasc. Dis., 107963. doi: 10.1016/j.jstrokecerebrovasdis.2024.107963.
9. Fiorentini D., Cappadone C., Farruggia G. Magnesium: Biochemistry, Nutrition, Detection, and Social Impact of Diseases Linked to Its Deficiency. Nutrients. 2021; 13(4): 1136.
10. Gragossian A., Bashir K., Bhutta B. et al. (2023) Hypomagnesemia. In: StatPearls. Treasure Island (FL): StatPearls Publ. http://www.ncbi.nlm.nih.gov/books/NBK500003/.
11. Hasan M., Nahar K., Sharif J. et al. (2023) Serum Magnesium Level and It’s Relation in Predicting Adverse In-Hospital Outcome in Patients with First Attack of Myocardial Infarction. Mymensingh Med. J., 2(1): 65–72.
12. Hossain M., Kharel M., Husna A. et al. (2023) Prevalence of Electrolyte Imbalance in Patients With Acute Stroke: A Systematic Review. Cureus, 15(8): e43149. doi: 10.7759/cureus.43149.
13. Hossain M., Bhattacharjee M,. Roy S. et al. (2024) Association of Serum Magnesium Level with Severity of Neurological Disability in Patients with Acute Ischemic Stroke. Mymensingh Med. J., 33(1): 9–15.
14. panangin.ru/specialistam/.
15. Ibrahim A., Legha R., Ravi R. et al. (2023) Association of serum magnesium levels with acute ischaemic stroke in patients with type 2 diabetes mellitus: a propensity score-matched case-control study. BMJ Open, 13(10): e073997. doi: 10.1136/bmjopen-2023-073997.
16. Khafri S., Ahmadi Ahangar A. et al. (2024) Mediatory role of the serum mineral level and discharge disability of stroke survivors. Caspian J. Intern. Med., 15(1): 124–131.
17. Khanum M., Arshad U., Ullah I. (2024) Frequency of Hypomagnesemia and Its Relationship With Severity Among Patients of Acute Ischemic Stroke Presenting to a Tertiary Care Hospital. Cureus, 16(4): e58244. doi: 10.7759/cureus.58244
18. Lewis J. Overview of Disorders of Potassium Concentration (2023) http://www.msdmanuals.com/professional/endocrine-and-metabolic-disorders/electrolyte-disorders/overview-of-disorders-of-potassium-concentration.
19. Linde C., Qin L., Bakhai A. et al. (2019) Serum potassium and clinical outcomes in heart failure patients: results of risk calculations in 21 334 patients in the UK. ESC Heart Fail., 6(2): 280–290. doi: 10.1002/ehf2.12402.
20. Liotta E., Maas M., Prabhakaran S. et al. (2024) Magnesium and Hematoma Expansion in Intracerebral Hemorrhage: A FAST-MAG Randomized Trial Analysis. Stroke, 55(2): 463–466.
21. Liu C., Qiu L., Zhang Y. et al. (2024) The interaction between estimated glomerular filtration rate and dietary magnesium intake and its effect on stroke prevalence: a cross-sectional study spanning 2003–2018. Front. Nutr., 11: 1395685. doi: 10.3389/fnut.2024.1395685.
22. Moniruzzaman A.H.M., Uddin M.J., Battacharjee M. et al. (2024) Study of Serum Electrolytes (Sodium and Potassium) Abnormalities in Acute Stroke. Mymensingh. Med. J., 33(2): 321–326.
23. Orlova N., Kovtun G., Holovchanska-Pushkar S. et al. (2024) Non-communicable diseases and their risk factors in Ukraine: analysis of the global burden of disease 2019 study. Wiad Lek., 77(4): 682–689. doi: 10.36740/WLek202404111.
24. Sabah Z., Wani J., Deajim M. et al. (2023) Serum Magnesium in Patients With Acute Myocardial Infarction and Its Effect on Cardiac Complications and Mortality in Myocardial Infarction Patients. Cureus, 15(4): e38147. doi: 10.7759/cureus.38147.
25. Salman E., Kadota A., Miura K. (2024) Global guidelines recommendations for dietary sodium and potassium intake. Hypertens. Res., 47(6): 1620–1626.
26. Segev A., Shechter M., Tsur A. et al. (2023) Serum Magnesium Is Associated with Long-Term Survival of Non-ST-Elevation Myocardial Infarction Patients. Nutrients, 15(19): 4299.
27. Shkoruta D.P., Senkiv V., Vovchuk V. et al. (2024) Impact of war on stroke incidence in Ivano-Frankivsk, Ukraine. Sci. Rep., 14(1): 18996. doi: 10.1038/s41598-024-70270-4.
28. Tawakul A., Alluqmani M., Badawi A. et al. (2024) Risk Factors for Cerebral Vasospasm After Subarachnoid Hemorrhage: A Systematic Review of Observational Studies. Neurocrit. Care.
29. Wang A., Cao S., Tian X. et al. (2022) Lower Serum Potassium Levels at Admission are Associated with the Risk of Recurrent Stroke in Patients with Acute Ischemic Stroke or Transient Ischemic Attack. Cerebrovasc Dis., 51(3): 304–312. doi: 10.1159/000520052.
30. Wang M., Peng J., Yang C. et al. (2023) Magnesium intake and all-cause mortality after stroke: a cohort study. Nutr J., 22(1): 54. doi: 10.1186/s12937-023-00886-1.
31. Wang X., Liang M., Zeng F. et al. (2022) Predictive role of modifiable factors in stroke: an umbrella review. BMJ Open, 12(6): e056680. doi: 10.1136/bmjopen-2021-056680.
32. Wipplinger C., Cattaneo A., Wipplinger T. (2023) Serum concentration-guided intravenous magnesium sulfate administration for neuroprotection in patients with aneurysmal subarachnoid hemorrhage: a retrospective evaluation of a 12-year single-center experience. Neurosurg Rev., 46(1): 256. doi: 10.1007/s10143-023-02159-1.
33. Wu Y., Kong X.J., Ji Y. et al. (2024) Serum electrolyte concentrations and risk of atrial fibrillation: an observational and mendelian randomization study. BMC Genomics., 25(1): 280.
34. Xu Q., Hu L., Chen L. et al. (2023) Low serum magnesium is associated with poor functional outcome in acute ischemic stroke or transient ischemic attack patients. CNS Neurosci. Ther., 29(3): 842–854. doi: 10.1111/cns.14020.
35. Zhao L., Hu M., Yang L. et al. (2019) Quantitative Association Between Serum/Dietary Magnesium and Cardiovascular Disease/Coronary Heart Disease Risk: A Dose-Response Meta-analysis of Prospective Cohort Studies. J. Cardiovasc. Pharmacol., 74(6): 516–527.
36. Zheng T., Wang J., Meng Q. et al. (2021) Effect of dynamic stratified potassium supplementation in elderly patients with chronic heart failure and moderate to severe hypokalaemia-a randomised, controlled trial. J. Int. Med. Res., 49(10): 3000605211053550.
37. Zoellner E., Patterson M., Sharrief A. et al. (2023) Dietary Intake and Quality among Stroke Survivors: NHANES 1999–2018. J. Nutr., 153(10): 3032–3040.
38. Інфаркт в Україні «помолодшав» на 10 років: Ляшко про наслідки війни для здоров’я. 2023. suspilne.media/357098-infarkt-v-ukraini-pomolodsav-na-10-rokiv-lasko-pro-naslidki-vijni-dla-zdorova/.